Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,532.7
17.0 (0.68%)

 

  • STI Straits Times Index
    2,532.7
    17.0 (0.68%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,568.1
    -7.8 (-0.50%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    25,102.5
    155.9 (0.62%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,377.6
    5.9 (0.17%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,514.8
    -58.8 (-0.26%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,127.1
    52.0 (1.03%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,493.1M
  • Value: 1,391.4M
  • Rise: 221
  • Fall: 111
  • Unch: 476

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Rex Intl0.186+0.003
Leader Env0.064+0.008
AnAn Intl0.043+0.008
Synagie0.194+0.005
LionGold0.002-
Genting Sing0.710-0.020
Medtecs Intl1.010+0.025
ISDN0.370+0.070
CNMC Goldmine0.355+0.045
Anchor Resources0.009+0.002

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,246.6 -303.4
HSCEI 9,742.1 -111.1
Jakarta 4,863.1 -41.0
Nikkei 225 22,062.1 -450.0
SSE Comp 2,958.7 -11.9
Shanghai A 3,101.3 -12.4
Shanghai B 211.6 -1.8
KOSPI 2,098.0 -36.7

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

ONCOSIL MEDICAL LIMITED ONCOSIL MEDICAL
Updated on 05 Aug 2020 (End of trading day)
Last (AUD): 0.110 Change: - High: 0.115 Remarks: -
Change (%): - Low: 0.110
Open 0.110 Yesterday's Close 0.11
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 320,801 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (AUD) a -0.01034 Trailing EPS (AUD) e -0.00823 NAV (AUD) b 0.0088
PE a - Trailing PE f - Price / NAV b 12.5000
Dividend (AUD) d - Cash In Hand (AUD) g 0.0082 Issued & Paid-up Shares c 828,601,000
Dividend Yield (%) d - Price / Cash In Hand g 13.415 Treasury Shares h -
Beta - 75 Daysi -0.253 R-Squared - 75 Days(%)i 0.34 Market Cap (M) 91.146
Beta - 500 Daysi 0.709 R-Squared - 500 Days (%)i 0.50 Enterprise Value (M) 84.580
Piotroski F Score 2 Exchange Code OSL Par Value ( AUD ) n.a.
52 Weeks Volatility (%) 72.07 Free Float (%) 75.8
Sector & Industry Health Technology - Pharmaceuticals: Major
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 30 Jun 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 30 Jul 2015.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference ONCOSIL MEDICAL LIMITED ASX 91.146 - - 12.5000 -
Industry Pharmaceuticals: Major ASX 97.778 - - 8.1831 -
Local Peer AFT PHARMACEUTICALS LTD ASX 446.951 40.213 40.211 26.7370 -
Local Peer STARPHARMA HOLDINGS LIMITED ASX 404.231 - - 10.6164 -
Local Peer PYC THERAPEUTICS LIMITED ASX 351.790 - - 11.0092 -
Local Peer RECCE PHARMACEUTICALS LTD ASX 199.674 - - 42.3547 -
Local Peer PALLA PHARMA LTD ASX 103.277 - - 1.4462 -
Local Peer RACE ONCOLOGY LTD ASX 107.423 - - 19.6629 -
Local Peer IMMURON LIMITED ASX 81.796 - - 11.9281 -
Local Peer NOXOPHARM LTD ASX 68.224 - - -18.8235 -
Local Peer TBG DIAGNOSTICS LTD ASX 58.748 - - 4.5685 -
Local Peer INVION LTD ASX 49.505 - - 10.0000 -
Local Peer MEDLAB CLINICAL LIMITED ASX 40.553 - - 3.2009 -
Local Peer PHARMAXIS ASX 38.734 - - 27.2222 -
Other Local Peers ACRUX (ASX), EXOPHARM LTD (ASX), TALI DIGITAL LIMITED (ASX), CELLMID LIMITED (ASX), SUDA PHARMACEUTICALS LTD (ASX), CRESO PHARMA LTD (ASX), FIJI KAVA LTD (ASX), FARMAFORCE LTD (ASX)
Global Peer JOHNSON & JOHNSON NYSE 387,603.760 25.637 25.525 6.1546 2.547
Global Peer PFIZER INC NYSE 213,249.924 13.105 15.049 - 3.789
Global Peer NOVARTIS AG ADR-EACH REPR 1 CHF0.5(REGD) NYSE 207,603.099 29.455 28.761 3.8580 2.189
Global Peer MERCK & CO INC NYSE 206,143.247 20.943 19.672 - 2.784
Global Peer ABBVIE INC NYSE 166,171.039 21.190 24.013 - 3.907
Global Peer ELI LILLY AND COMPANY NYSE 148,109.380 31.935 26.363 36.1867 1.668
Global Peer ASTRAZENECA SPON ADR EACH REP 0.50 ORD SHS NYSE 147,184.203 109.795 105.519 - 2.443
Global Peer BRISTOL-MYERS SQUIBB CO NYSE 134,562.174 39.128 141.050 2.6960 2.782
Global Peer SANOFI SPON ADR ECH REP 0.5 ORD SHS NASDAQ 130,400.487 40.078 40.078 - 2.257
Global Peer NOVO NORDISK A/S ADR-EACH CNV INTO 1 CLASS B DKK1 NYSE 117,145.753 20.062 19.496 14.6454 1.759
Other Global Peers GLAXOSMITHKLINE ADR EACH CNV INTO 2 ORD GBP0.25 (NYSE), TAKEDA PHARMACEUTICAL CO LTD SPON ADS EACH REP 0.5 ORD SHS (NYSE), WUXI APPTEC (HKEx), ROYALTY PHARMA PLC (NASDAQ), HANSOH PHARMA (HKEx), INNOVENT BIO (HKEx), REPLIGEN CORP (NASDAQ), SINOPHARM (HKEx), CANSINOBIO-B (HKEx), JUNSHI BIO (HKEx), SH PHARMA (HKEx), REATA PHARMACEUTICALS INC (NASDAQ), GRIFOLS SA SPON ADR EA REPR 1 ORD EUR0.10 (NASDAQ), BAIYUNSHAN PH (HKEx), LEGEND BIOTECH CORP SPON ADS EACH REP 2 ORD SHS (NASDAQ), HUTCHISON CHINA MEDITECH SPON ADS EACH REPR 5 ORD SHS (NASDAQ), HENLIUS-B (HKEx), NEKTAR THERAPEUTICS (NASDAQ), ALLAKOS INC (NASDAQ), BIOHAVEN PHARMACEUTICAL HLDG CO LTD (NYSE), CHINARES PHARMA (HKEx), CHINAGRANDPHARM (HKEx), OPKO HEALTH INC (NASDAQ), ADC THERAPEUTICS SA (NYSE), CMS (HKEx), AKESO-B (HKEx), HEPALINK (HKEx), HYGEIA HEALTH (HKEx), PRINCIPIA BIOPHARMA INC (NASDAQ), TRAD CHI MED (HKEx), INNOCARE-B (HKEx), TURNING POINT THERAPEUTICS INC (NASDAQ), OCUMENSION-B (HKEx), KARUNA THERAPEUTICS INC (NASDAQ), APELLIS PHARMACEUTICALS INC (NASDAQ), SSY GROUP (HKEx), SPRINGWORKS THERAPEUTICS INC (NASDAQ), I MAB SPON ADS EACH REP 2.3 ORD SHS (NASDAQ), IGM BIOSCIENCES INC (NASDAQ), UNITED LAB (HKEx), Y-MABS THERAPEUTICS INC (NASDAQ), FORMA THERAPEUTICS HLDGS INC (NASDAQ), ZYMEWORKS INC (NYSE), CSTONE PHARMA-B (HKEx), AMNEAL PHARMACEUTICALS INC (NYSE), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), CONSTELLATION PHARMACEUTICALS INC (NASDAQ), ARCTURUS THERAPEUTICS HOLDINGS INC (NASDAQ), KINIKSA PHARMACEUTICALS LTD (NASDAQ), AKERO THERAPEUTICS INC (NASDAQ), CKLIFE SCIENCES (HKEx), ODONATE THERAPEUTICS INC (NASDAQ), AKCEA THERAPEUTICS INC (NASDAQ), Kimia Farma Tbk. (IDX), TONGRENTANGCM (HKEx), PETIQ INC (NASDAQ), GOSSAMER BIO INC (NASDAQ), PHATHOM PHARMACEUTICALS INC (NASDAQ), ARCUTIS BIOTHERAPEUTICS INC (NASDAQ), PHIBRO ANIMAL HEALTH CORP (NASDAQ), GENERATION BIO CO (NASDAQ), QUANTERIX CORPORATION (NASDAQ), ATHENEX INC (NASDAQ), HUA MEDICINE-B (HKEx), REPARE THERAPEUTICS INC (NASDAQ), KRYSTAL BIOTECH INC (NASDAQ), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), TRICIDA INC (NASDAQ), ANNEXON INC (NASDAQ), NURIX THERAPEUTICS INC (NASDAQ), IMMUNOTECH-B (HKEx), ORIC PHARMACEUTICALS INC (NASDAQ), KEROS THERAPEUTICS INC (NASDAQ), PROVENTION BIO INC (NASDAQ), OYSTER POINT PHARMA INC (NASDAQ), APREA THERAPEUTICS INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), G1 THERAPEUTICS IN (NASDAQ), MIRUM PHARMACEUTICALS INC (NASDAQ), RELMADA THERAPEUTICS INC (NASDAQ), FUSION PHARMACEUTICALS INC (NASDAQ), CALLIDITAS THERAPEUTICS AB SPON ADS EACH REP 2 ORD SHS (NASDAQ), INOZYME PHARMA INC (NASDAQ), IGBB (Bursa), SIGA TECHNOLOGIES INC (NASDAQ), OCULAR THERAPEUTIX INC (NASDAQ), 89BIO INC (NASDAQ), SHINEWAY PHARM (HKEx), KALA PHARMACEUTICALS INC (NASDAQ), TCR2 THERAPEUTICS INC (NASDAQ), AC IMMUNE SA (NASDAQ), ORCHARD THERAPEUTICS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), BIOSPECIFICS TECHNOLOGIES CORP (NASDAQ), CRINETICS PHARMACEUTICALS INC (NASDAQ), DURECT CORP (NASDAQ), FULCRUM THERAPEUTICS INC (NASDAQ), SATSUMA PHARMACEUTICALS INC (NASDAQ), OVID THERAPEUTICS INC (NASDAQ), TOT BIOPHARM-B (HKEx), AMRYT PHARMA PLC (NEW) SPON ADS EACH REP 5 ORD SHS (NASDAQ), OSMOTICA PHARMACEUTICALS PLC (NASDAQ), BEYONDSPRING INC (NASDAQ), IMARA INC (NASDAQ), AMAG PHARMACEUTICS INC (NASDAQ), FUSEN PHARM (HKEx), BSTEAD (Bursa), IDEAYA BIOSCIENCES INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), SUTRO BIOPHARMA INC (NASDAQ), MENLO THERAPEUTICS INC (NASDAQ), PHARMA (Bursa), IMMUNIC INC (NASDAQ), SPERO THERAPEUTICS INC (NASDAQ), HOOKIPA PHARMA INC (NASDAQ), UROVANT SCIENCES LTD (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), BIONDVAX PHARMACEUTICALS SPON ADS REP 40 ORD SHS (NASDAQ), LANNETT CO INC (NYSE), POLYPID LTD (NASDAQ), KALEIDO BIOSCIENCES INC (NASDAQ), MILESTONE PHARMACEUTICALS INC (NASDAQ), CH BIOTECH SER (HKEx), LIQUIDIA TECHNOLOGIES INC (NASDAQ), VERU INC (NASDAQ), SCPHARMACEUTICALS INC (NASDAQ), KALVISTA PHARMACEUTICALS INC (NASDAQ), GAMIDA CELL LTD (NASDAQ), THERATECHNOLOGIES INC (NASDAQ), LOGICBIO THERAPEUTICS INC (NASDAQ), AQUESTIVE THERAPEUTICS INC (NASDAQ), NEUBASE THERAPEUTICS INC (NASDAQ), SOL GEL TECHNOLOGIES LTD (NASDAQ), GALERA THERAPEUTICS INC (NASDAQ), EVELO BIOSCIENCES INC (NASDAQ), LYRA THERAPEUTICS INC (NASDAQ), MUSTANG BIO INC (NASDAQ), DAWNRAYS PHARMA (HKEx), AVENUE THERAPEUTICS INC (NASDAQ), ZHONGZHIPHARM (HKEx), VERRICA PHARMACEUTICALS INC (NASDAQ), AYALA PHARMACEUTICALS INC (NASDAQ), TYME TECHNOLOGIES INC (NASDAQ), TFF PHARMACEUTICALS INC (NASDAQ), PROTARA THERAPEUTICS INC (NASDAQ), HARROW HEALTH INC (NASDAQ), XERIS PHARMACEUTICALS INC (NASDAQ), ETON PHARMACEUTICALS INC (NASDAQ), GENPREX INC (NASDAQ), ESSA PHARMA INC (NASDAQ), OBSEVA SA (NASDAQ), CYCLERION THERAPEUTICS INC (NASDAQ), KITOV PHARMA LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), IX Biopharma (SGX), Hyphens Pharma (SGX), CHECKPOINT THERAPEUTICS INC (NASDAQ), BIOMX INC (NYSE American), GRITSTONE ONCOLOGY INC (NASDAQ), KOTRA (Bursa), PHASEBIO PHARMACEUTICALS INC (NASDAQ), CORVUS PHARMACEUTICALS INC (NASDAQ), Merck Tbk. (IDX), APTORUM GROUP LIMITED (NASDAQ), NOVAN INC (NASDAQ), EVOLUS INC (NASDAQ), MEDIWOUND LTD (NASDAQ), Phapros Tbk. (IDX), ASSERTIO HOLDINGS INC (NASDAQ), ADAMIS PHARMACEUTICALS CORPORATION (NASDAQ), NEW RAY MEDIC (HKEx), EYEPOINT PHARMACEUTICALS INC (NASDAQ), NOVA (Bursa), BIOHLDG (Bursa), TREVI THERAPEUTICS INC (NASDAQ), CLEARSIDE BIOMEDICAL INC (NASDAQ), PAK FAH YEOW (HKEx), LANTERN PHARMA INC (NASDAQ), EYENOVIA INC (NASDAQ), PDS BIOTECHNOLOGY CORPORATION (NASDAQ), NC HEALTHCARE (HKEx), MOLECULIN BIOTECH INC (NASDAQ), IP (SET), CHARMACY PHAR (HKEx), AKARI THERAPEUTICS PLC SPON ADR EACH REPR 100 ORD (NASDAQ), ARIDIS PHARMACEUTICAL INC (NASDAQ), BAUDAX BIO INC (NASDAQ), EDESA BIOTECH INC (NASDAQ), CITIUS PHARMACEUTICALS INC (NASDAQ), AGEX THERAPEUTICS INC (NYSE American), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), ADDEX THERAPEUTICS LIMITED SPON ADS EACH REP 6 ORD SHS (NASDAQ), ALLENA PHARMACEUTICALS INC (NASDAQ), AERPIO PHARMACEUTICALS INC (NASDAQ), ONCTERNAL THERAPEUTICS INC (NASDAQ), NEP INTERLONG (HKEx), ACER THERAPEUTICS INC (NASDAQ), MANNATECH INC (NASDAQ), AILERON THERAPEUTICS INC (NASDAQ), WAI YUEN TONG (HKEx), ANNOVIS BIO INC (NYSE American), HOTH THERAPEUTICS INC (NASDAQ), SANAI HEALTH GP (HKEx), HISTOGEN INC (NASDAQ), JCT (SET), MILLENDO THERAPEUTICS INC (NASDAQ), ENTERA BIO LTD (NASDAQ), CNS PHARMACEUTICALS INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), PURAPHARM (HKEx), EXTRAWELL PHAR (HKEx), TITAN PHARMACEUTICAL INC (NASDAQ), SPRING BANK PHARMACEUTICALS INC (NASDAQ), BRICKELL BIOTECH INC (NASDAQ), CHINA SXT PHARMACEUTICALS INC (NASDAQ), ADIAL PHARMACEUTICALS INC (NASDAQ), TIMBER PHARMACEUTICALS INC (NYSE American), SUNZEN (Bursa), PROPHASE LABS INC (NASDAQ), PASHUN INT'L (HKEx), SINOLIFE UTD (HKEx), TELIGENT INC NEW (NASDAQ), Merck Sharp Dohme Pharma Tbk. (IDX), NOVUS THERAPEUTICS INC (NASDAQ), Pharmesis Intl (SGX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.010
-8.33 %
10 Days --0.015
-12.00 %
20 Days --0.015
-12.00 %
Medium Term Return 3 Months ---
6 Months --0.076
-40.86 %
1 Year -+0.044
+66.67 %
Long Term Return 2 Years --0.086
-43.88 %
3 Years -+0.014
+14.58 %
5 Years -+0.002
+1.85 %
Annualised Return Annualised --
+0.37 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.056 - 0.211 Change From 1 Year Low +0.054 % Change From 1 Year Low (%) +96.78
Change From 1 Year High -0.101 % Change From 1 Year High (%) -47.84
2 Years Range 0.021 - 0.226 Change From 2 Years Low +0.089 % Change From 2 Years Low (%) +433.98
Change From 2 Years High -0.116 % Change From 2 Years High (%) -51.24
5 Years Range 0.021 - 0.270 Change From 5 Years Low +0.089 % Change From 5 Years Low (%) +433.98
Change From 5 Years High -0.160 % Change From 5 Years High (%) -59.21
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

OncoSil Medical Ltd. develops and commercializes neurology services, including those for pancreatic cancer. It engages in the development of novel and safer radiation therapy treatments. The company was founded by David McAuliffe on April 14, 2005 and is headquartered in North Sydney, Australia.

Historical Price Data

Date Open High Low Close Volume VWAP
05 Aug 2020 0.110 0.115 0.110 0.110 320,801 -
04 Aug 2020 0.110 0.110 0.110 0.110 606,181 -
03 Aug 2020 0.110 0.110 0.105 0.105 1,097,273 -
31 Jul 2020 0.120 0.120 0.110 0.110 6,020,628 -
30 Jul 2020 0.120 0.120 0.115 0.115 1,080,429 -
29 Jul 2020 0.120 0.120 0.115 0.120 1,076,977 -
28 Jul 2020 0.125 0.130 0.115 0.120 3,823,462 -
27 Jul 2020 0.125 0.125 0.120 0.120 1,186,388 -
24 Jul 2020 0.125 0.125 0.120 0.120 830,343 -
23 Jul 2020 0.125 0.125 0.120 0.120 621,316 -
22 Jul 2020 0.115 0.125 0.115 0.125 1,081,019 -
21 Jul 2020 0.115 0.120 0.115 0.115 1,604,459 -
20 Jul 2020 0.115 0.120 0.115 0.115 274,772 -
17 Jul 2020 0.120 0.120 0.115 0.115 3,675,463 -
16 Jul 2020 0.120 0.120 0.120 0.120 970,778 -
15 Jul 2020 0.120 0.120 0.115 0.115 584,628 -
14 Jul 2020 0.120 0.125 0.115 0.120 1,683,714 -
13 Jul 2020 0.125 0.125 0.122 0.125 2,761,844 -
10 Jul 2020 0.135 0.135 0.125 0.125 1,183,960 -
09 Jul 2020 0.125 0.135 0.125 0.130 730,728 -
08 Jul 2020 0.130 0.130 0.125 0.125 1,152,186 -
07 Jul 2020 0.130 0.140 0.130 0.130 4,968,441 -
Summary
Current 2 Weeks
(23 Jul 2020 to 05 Aug 2020)
0.125 0.130 0.105 0.110 16,663,798 -
Previous 2 Weeks
(09 Jul 2020 to 22 Jul 2020)
0.125 0.135 0.105 0.125 14,551,365 -
4 Weeks from
(10 Jun 2020 to 08 Jul 2020)
0.130 0.135 0.105 0.125 43,478,207 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.